Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: mmeggs who wrote (377)	10/25/1998 4:41:00 AM
From: DAGOBERT	Read Replies (1) \| Respond to of 410

Hi, did you not read about the restenosis comparison between J&J Palmaz-Schatz stent and AVE's XT coronary stent?

To: mmeggs who wrote (377)	10/27/1998 4:15:00 PM
From: Scott Overholser	Read Replies (1) \| Respond to of 410

i think you hit the nail on the head ... "CRUSHED expectations for the last three quarters." i agree. i simply pointed out that ave didn't "CRUSH" expectations this quarter and earnings were down sequentially to boot. it's only my take on the market action. price action confirms (in my own mind) the explanation. you know what they say - if it walks like a duck and quacks like a duck... just remember that all stocks are bad stocks - except when they go up. But to say that they didn't exceed expectations by as high a percentage as two previous quarters, and that is why they are down, is patently absurd. patently absurd?! why do you say such inflammatory things o' omniscient one?